+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID03756870

Comparing PCI Using Drug-Eluting Stents Versus Optimal Medical Therapy to Reduce Heart Ischemia in Patients with Chronic Total Coronary Occlusion

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2026-07-06

48

Participants Needed

1

Research Sites

161 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with chronic total occlusion CTO of a coronary artery to evaluate whether percutaneous coronary intervention PCI can reduce heart ischemia more effectively than optimal medical therapy alone. The study focuses on patients selected based on an ischemic threshold greater than 12.5% on cardiac imaging. It aims to understand how PCI impacts ischemic burden, left ventricular function, infarct size, and functional status compared to medical therapy without PCI. Participants are randomly assigned to receive either PCI using a drug-eluting stent plus optimal medical therapy or optimal medical therapy alone without PCI. The intervention involves a percutaneous procedure targeting the occluded artery. The study includes a 6-month follow-up period to assess ischemia reduction using exercise myocardial perfusion SPECT-CT imaging and cardiac magnetic resonance imaging to evaluate heart function and viability. During the trial, participants undergo baseline and follow-up SPECT and cardiac MRI scans, along with assessments of angina symptoms and quality of life using validated questionnaires over up to 10 years. Researchers monitor changes in ischemic burden, heart function, and patient-reported outcomes to measure the effects of PCI versus medical therapy. Participants provide informed consent and attend scheduled visits, including the 6-month follow-up imaging, with the study continuing through 2030.

CONDITIONS

Brief Title

Revascularization Versus Optimal Medical Therapy of Chronic Total Coronary Occlusions on Left Ventricular Ischemia Reduction

Research Team

P

Prof. J.P.S. Henriques, MD PhD

M

Ms. A. van Veelen, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here